Timothy M. Mayleben - Jun 17, 2022 Form 4 Insider Report for Landos Biopharma, Inc. (LABP)

Role
Director
Signature
/s/ Eric W. Blanchard, Attorney-in-Fact
Stock symbol
LABP
Transactions as of
Jun 17, 2022
Transactions value $
$0
Form type
4
Date filed
6/22/2022, 04:29 PM
Previous filing
Feb 7, 2022
Next filing
Jan 30, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LABP Stock Option (right to buy) Award $0 +18K $0.00 18K Jun 17, 2022 Common Stock 18K $0.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option will vest and become exercisable on June 7, 2023, subject to the Reporting Person providing continuous service through such date.